CAS: 3312-04-7; 4,4'-(4-Chlorobutane-1,1-Diyl)Bis(Fluorobenzene)

该化合物是有机化合物,其结构特征包括一个由两个四氟苯基组和一个氯原子替代的丁烷骨柱,该化合物一般在室温中处于固态,以其在包括制药和材料科学在内的各个领域的潜在应用而著称.在苯基组中存在氟原子可以加强化合物的亲眼性和稳定性,而氯原子可能会影响其在有机溶剂中的再活动性和溶解性.该化合物的分子结构表明,该化合物可能由于氟和氯子子体的电拔性质而参与电极性芳香替代反应.此外,该化合物的独特性可能使其能够作为合成更复杂的分子的建筑块.在处理和储存时,应参考安全数据,因为卤化化合物可能对健康和环境造成风险.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号2062-78-4 匹莫齐特 | CAS号50337-85-4 4,4-bis(4-fluor... | CAS号51787-79-2 1,1'-(4-iodobut... | CAS号51787-82-7 8-[4,4-bis(4-fl... | CAS号61668-03-9 1-fluoro-4-[1-(...

合成工艺路线路线简述

    📜4,4'-二氟二苯甲酮置于吡啶,氯化亚砜,5%-Palladium/activated Carbon,氢气,对甲苯磺酸,Magnesium体系中,用 四氢呋喃,水,异丙醇,甲苯 作为反应溶剂,25.0~80.0 °C,500.01 Kpa 条件下,反应 24.0H,反应生成 4,4,-二(4-氟苯)氯丁烷
    参考文献: Process For The Preparation Of A Fluspirilene Intermediate[fr] Procédé De Préparation D'Un Intermédiaire Fluspirilène
    标题: Process For The Preparation Of A Fluspirilene Intermediate[fr] Procédé De Préparation D'Un Intermédiaire Fluspirilène
    摘要:本发明涉及一种制备4,4'-双(氟苯)衍生物的方法,该化合物是一些药物的合成中间体,例如在fluspirilene的合成中.本发明还涉及新的合成中间体化合物.

    海关参考信息

    专利信息


    专利号:WO-2016071723-A1
    优先权日:2014-11-03
    标题:Process for the preparation of a fluspirilene intermediate
    发明人:FELICIANI LAZZARO; VISCARDI ENRICO; CREMONESI GIUSEPPE
    权利人:SIFAVITOR S R L
    摘要:The present invention relates to a process for the preparation of a 4,4'- bis(fluorobenzene) derivative, which is an intermediate compound in the synthesis of some drugs, for example in the synthesis of fluspirilene. The invention further relates to new synthetic intermediate compounds.

    专利号:US-9156840-B2
    优先权日:2010-06-18
    标题:D2 antagonists, methods of synthesis and methods of use
    发明人:LUEHR GARY W; SUNDARAM ARATHI; JAISHANKAR PRIYADARSHINI; PAYNE PHILIP W; DRUZGALA PASCAL
    权利人:ALTOS THERAPEUTICS LLC
    摘要:Provided are D 2 or D 3 antagonist compounds and pharmaceutical compositions of formula I n nand pharmaceutically acceptable salts thereof, or isomers thereof, wherein R 1 , R 2 and R 3 are as defined herein. The invention further comprises methods for making the compounds of the invention and methods for the treatment of conditions mediated by the dopamine D 2 or D 3 receptor from the compounds of the invention.

    专利号:US-8691836-B2
    优先权日:2010-06-18
    标题 :D2 antagonists, methods of synthesis and methods of use

    专利号:US-2014350005-A1
    优先权日:2010-06-18
    标题 :D2 antagonists, methods of synthesis and methods of use

    专利号:CN-103052636-A
    优先权日:2010-06-18
    标 题:D2 antagonists, methods of synthesis and methods of use

    专利号:US-2012010228-A1
    优先权日:2010-06-18
    标 题 :D2 antagonists, methods of synthesis and methods of use

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知